Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated

A. V. Sears; R. T. Woolf; E. Gribaleva; W. Abdelrahman; S. Robbie; B. Menon; B. Kirkham; C. H. Smith; A. E. Pink

doi:10.1111/bjd.19631

Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated

A. V. Sears, R. T. Woolf^*, E. Gribaleva, W. Abdelrahman, S. Robbie, B. Menon, B. Kirkham, C. H. Smith, A. E. Pink

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Letter › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	755-757
Number of pages	3
Journal	British Journal of Dermatology
Volume	184
Issue number	4
DOIs	https://doi.org/10.1111/bjd.19631
Publication status	Published - Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bjd.19631

Cite this

Sears, A. V., Woolf, R. T., Gribaleva, E., Abdelrahman, W., Robbie, S., Menon, B., Kirkham, B., Smith, C. H., & Pink, A. E. (2021). Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated. British Journal of Dermatology, 184(4), 755-757. https://doi.org/10.1111/bjd.19631

@article{65d65428d8b74128bc211c51fe9cad85,

title = "Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated",

author = "Sears, {A. V.} and Woolf, {R. T.} and E. Gribaleva and W. Abdelrahman and S. Robbie and B. Menon and B. Kirkham and Smith, {C. H.} and Pink, {A. E.}",

year = "2021",

month = apr,

doi = "10.1111/bjd.19631",

language = "English",

volume = "184",

pages = "755--757",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "4",

}

Sears, AV, Woolf, RT, Gribaleva, E, Abdelrahman, W, Robbie, S, Menon, B, Kirkham, B , Smith, CH & Pink, AE 2021, 'Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated', British Journal of Dermatology, vol. 184, no. 4, pp. 755-757. https://doi.org/10.1111/bjd.19631

Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated. / Sears, A. V.; Woolf, R. T.; Gribaleva, E. et al.
In: British Journal of Dermatology, Vol. 184, No. 4, 04.2021, p. 755-757.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis

T2 - a single-centre, prospective 1-year observational cohort study of the first 100 patients treated

AU - Sears, A. V.

AU - Woolf, R. T.

AU - Gribaleva, E.

AU - Abdelrahman, W.

AU - Robbie, S.

AU - Menon, B.

AU - Kirkham, B.

AU - Smith, C. H.

AU - Pink, A. E.

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85101805929&partnerID=8YFLogxK

U2 - 10.1111/bjd.19631

DO - 10.1111/bjd.19631

M3 - Letter

C2 - 33107978

AN - SCOPUS:85101805929

SN - 0007-0963

VL - 184

SP - 755

EP - 757

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -

Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated

UN SDGs

Access to Document

Other files and links

Cite this